PathAI
Level 25: Medicine, Diagnostics & Medical Technology
Health & Environment · Level 25
In short
PathAI is an AI tool in the Biology & Medicine category from PathAI, Inc. in Boston, United States. The pricing model is paid. It is available in English only.
What is PathAI?
PathAI is a leading pathology technology company that leverages artificial intelligence to improve the accuracy of disease diagnosis and the development of targeted therapies. The platform processes high-resolution whole slide images (WSIs) and analyzes cellular structures using advanced deep learning algorithms. This supports pathologists in identifying tumor cells, evaluating histopathology, and detecting complex tissue patterns with enhanced precision.
The company's core technology suite includes image management tools and AI models tailored for academic research, clinical trials, and drug development pipelines. PathAI's flagship workflow platform, AISight, provides an integrated image management environment for pathology laboratories. Its algorithms quantify biomarkers, measure tissue alterations, and minimize inter-observer variability among diagnosticians.
By collaborating with global biopharmaceutical companies and research institutions, PathAI accelerates the development of precision oncology treatments. The system supports the entire lifecycle from preclinical research to biomarker-driven patient stratification and clinical deployment. Adhering to strict compliance standards, PathAI ensures secure handling of sensitive medical imaging data.
Core features & strengths
- AI-Powered Tissue Analysis — Automatic detection and quantification of cancerous cells and complex tissue features in whole slide images to improve diagnostic consistency.
- AISight Image Management Platform — A cloud-native solution designed for seamless viewing, annotation, and management of digital pathology workflows.
- Biopharma Biomarker Quantification — Specialized algorithms to accurately evaluate biomarkers for patient selection and endpoints in clinical drug trials.
Who is this tool for?
PathAI is designed for pathology laboratories, academic medical centers, oncologists, and biopharmaceutical companies seeking advanced AI solutions for digital pathology, diagnostics, and clinical trial drug development.
Typical use case
A biopharmaceutical enterprise conducting a late-stage oncology clinical trial needs reliable quantification of biomarker expression across thousands of patient tissue biopsies. PathAI's platform ingests digitized slides, automatically identifies tumor boundaries, and scores biomarker positivity with high consistency. This enables researchers to stratify patients accurately, reduce evaluation bias, and accelerate trial timelines.
What is PathAI good for?
- PathAI is designed for pathology laboratories, academic medical centers, oncologists, and biopharmaceutical companies seeking advanced AI solutions for digital pathology, diagnostics, and clinical trial drug development.
- A biopharmaceutical enterprise conducting a late-stage oncology clinical trial needs reliable quantification of biomarker expression across thousands of patient tissue biopsies.
- AI-Powered Tissue Analysis: Automatic detection and quantification of cancerous cells and complex tissue features in whole slide images to improve diagnostic consistency.
- AISight Image Management Platform: A cloud-native solution designed for seamless viewing, annotation, and management of digital pathology workflows.
- Biopharma Biomarker Quantification: Specialized algorithms to accurately evaluate biomarkers for patient selection and endpoints in clinical drug trials.
When a different tool fits better
PathAI is not suitable for individual consumers, non-medical image processing, or general text analysis tasks outside of life sciences. It should not be used for routine clinical diagnostics without proper regulatory approvals in the relevant jurisdiction.
Pricing & plans
Plans in detail
- Enterprise / Clinical SolutionsContact for pricingContact for pricingcustom
- AI-powered pathological diagnostics
- Integration into clinical workflows
- Pharmaceutical research partnerships
Good to know
- No public free or freemium version available.
- Pricing is determined on a custom basis depending on deployment scope and licensing needs.
Prices checked on 15/08/2026. Prices based on public provider information, without warranty. Euro amounts are approximations; the provider's pricing page prevails.
Supported languages
The software interface and scientific reports are currently available exclusively in English.
Interface = the tool's menu language, content = the language you can work in. Without guarantee — vendors keep expanding their language coverage.
Privacy & GDPR
Data flow: Medical image processing occurs on highly secure US-based cloud infrastructure (AWS/GCP) operating under strict regulatory and data privacy standards.
Training on your inputs: Customer and patient data are only utilized for model training if explicitly agreed upon in contractual research protocols and in de-identified form.
For companies: Enterprise clients and healthcare institutions execute formal B2B agreements, including Data Processing Addendums (DPAs), EU Standard Contractual Clauses, and HIPAA Business Associate Agreements (BAAs).
Practical advice: Protected Health Information (PHI) and personal data should only be ingested when appropriate BAAs, DPAs, and patient consents are fully established.
- GDPR:
- EU data protection regulation: defines how personal data may be processed and what rights you have (access, deletion, objection).
- SCC (Standard Contractual Clauses):
- EU model clauses that let a provider legally process data outside the EU.
- DPA:
- Data Processing Agreement: contractually binds the provider to process your data only on your instructions. Usually mandatory for companies.
- On-premises / local:
- The model runs on your own machine or server. Data never leaves your network — the safest option from a privacy standpoint.
- HIPAA / BAA:
- US health data rules. A BAA is the matching contract — in the EU it does not replace GDPR requirements.
Privacy data checked on 02/08/2026. Editorial summary based on public provider information — not legal advice. When in doubt, check the provider's current privacy terms.
Fact sheet
| Vendor | PathAI, Inc. |
|---|---|
| Headquarters | Boston, United States |
| Category | Biology & Medicine |
| Pyramid level | Level 25 – Medicine, Diagnostics & Medical Technology |
| Pricing model | Paid |
| Free forever option | No |
| Open Source | No |
| Entry plan | Enterprise / Clinical Solutions: Contact for pricing (Contact for pricing) |
| German | not supported |
| English | interface and content |
| Privacy classification | GDPR / EU |
| Data processing agreement | Enterprise clients and healthcare institutions execute formal B2B agreements, including Data Processing Addendums (DPAs), EU Standard Contractual Clauses, and HIPAA Business Associate Agreements (BAAs). |
Alternatives to PathAI
Still unsure? The AI Tool Finder shows you alternatives.